In healthcare, the margin for error on due diligence is razor-thin. Healthcare organizations operating in medical devices, digital health, pharma, and healthcare services face unique challenges: FDA enforcement, reimbursement cuts, and the need for timely intelligence that standard research processes can't deliver. CipherIntel closes that gap.
Our healthcare due diligence reports are structured around the questions that matter most in medical devices, digital health, pharma, and healthcare services: FDA 483s and warning letters, CMS reimbursement exposure, clinical trial signals, and malpractice history. We pull from FDA databases, CMS data, ClinicalTrials.gov, and cross-reference against multiple independent sources. The result is a documented intelligence brief, not a search engine summary.
For healthcare organizations handling medical device, digital health, and healthcare services acquisition diligence, the math on CipherIntel is straightforward: a $100 brief that flags a material issue before you've committed significant resources is the cheapest insurance in healthcare. At that price point, there's no reason not to run due diligence on every opportunity in the pipeline.
Use the intake form to submit your due diligence request. Include the target name, the clinical and regulatory context, and any areas of specific concern. Reports are delivered in 48 hours with full source citations — ready to share with your clinical and compliance leadership.